TWENTY-FIRST CENTURY GROUP, INC.
TWENTY-FIRST CENTURY GROUP, INC. filed a Q1 report for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) on April 17, 2026, reporting $24,000 in lobbying income.
Lobbying for NRX PHARMACEUTICALS INC (FORMERLY KNOWN AS NEURORX) · Pharmaceutical company
-
JACK FIELDS Former member of CongressPreviously held: Former Member of Congress
-
LISA D RULLIPreviously held: Former staffer, Committee on Merchant Marine & Fisheries; Natural Resources
Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.
Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.
Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD.
Research and treatment related to suicide prevention for veterans and patients with bipolar depression or PTSD within the Fiscal Year 2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Bill.